NASDAQ : GRCE

Grace Therapeutics, Inc. — Earnings Estimates

$2.43 USD

$0 (0.0%)

Volume
94.29K
Average Volume
520.58K
Market Capitalization
$39.55M
P/E Ratio
-4.37
Dividend Yield
0.00%
Price Target
$4.00
Year High
$5.18
Year Low
$1.79
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$8.10

Annual earnings financials

GRCE financial data with annual/quarterly toggle

GRCE GAAP EPS - Annual & Quarterly

GRCE Sales Revenue - Annual & Quarterly

GRCE Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

GRCE Estimated and Actual Revenue by Quarter
GRCE Estimated and Actual EPS by Quarter
GRCE Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-03-31 1 - - - - - -
2027-12-31 1 - - - - - -
2027-09-30 1 - - - - - -
2027-06-30 1 - - - - - -
2027-03-31 1 - - - - - -
2026-12-31 1 - - - - - -
GRCE Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-03-31 1 -3.04M -3.04M -3.04M - - -
2027-12-31 1 -2.75M -2.75M -2.75M - - -
2027-09-30 1 -1.99M -1.99M -1.99M - - -
2027-06-30 1 -2.37M -2.37M -2.37M - - -
2027-03-31 1 -2.13M -2.13M -2.13M - - -
2026-12-31 1 -2.13M -2.13M -2.13M - - -
GRCE Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-03-31 1 992.2K 992.2K 992.2K 1 -0.1842 -0.1842 -0.1842
2027-12-31 1 396.9K 396.9K 396.9K 1 -0.1664 -0.1664 -0.1664
2027-09-30 1 6.2M 6.2M 6.2M 1 -0.1205 -0.1205 -0.1205
2027-06-30 1 4.5M 4.5M 4.5M 1 -0.1437 -0.1437 -0.1437
2027-03-31 1 3.5M 3.5M 3.5M 1 -0.1293 -0.1293 -0.1293
2026-12-31 1 2.3M 2.3M 2.3M 1 -0.1293 -0.1293 -0.1293